Arvinas Announces Key Leadership Appointments in R&D
Company Announcements

Arvinas Announces Key Leadership Appointments in R&D

Arvinas Holding Company (ARVN) has provided an announcement.

Arvinas, Inc. has announced significant leadership changes with Ian Taylor, Ph.D. stepping in as the new president of R&D and Angela Cacace, Ph.D. taking over as chief scientific officer. Dr. Cacace, who has been with the company since 2018, will advance the research pipeline, while Dr. Taylor will provide strategic guidance for the company’s various projects in oncology and neuroscience, along with chairing the scientific advisory board. These appointments, approved by the board, mark a new chapter for Arvinas’s innovation and development efforts.

For a thorough assessment of ARVN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyArvinas price target lowered to $40 from $50 at Oppenheimer
TipRanks Auto-Generated NewsdeskArvinas Reports Progress in Q3 2024 Financials and Trials
TheFlyArvinas price target lowered to $40 from $50 at Oppenheimer
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App